CERS vs CLOV
Cerus Corporation (CERS) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
CERS currently screens at market cap $294.4M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the CERS and CLOV stock pages for the full models.
Not investment advice.